Monitoring the European standard series in 10 centres 1996-2000

被引：56

作者：

Bruynzeel, DP

Diepgen, TL

Andersen, KE

Brandao, FM

Bruze, M

Frosch, PJ

Goossens, A

Lahti, A

Mahler, V

Maibach, HI

Menné, T

Wilkinson, JD

机构：

[1] VU Univ Med Ctr, Dept Occupat Dermatol, NL-1081 HV Amsterdam, Netherlands

[2] Univ Hosp, Heidelberg, Germany

[3] Univ So Denmark, Odense Univ Hosp, Odense, Denmark

[4] Hosp Garcia Orta, Almada, Portugal

[5] Malmo Univ Hosp, Malmo, Sweden

[6] Univ Witten Herdecke, Dortmund, Germany

[7] Univ Hosp KU Leuven, Louvain, Belgium

[8] Univ Oulu, Oulu, Finland

[9] Univ Hosp, Erlangen, Germany

[10] Univ Calif San Francisco, Sch Med, San Francisco, CA USA

[11] Gentofte Univ Hosp, Copenhagen, Denmark

[12] Amersham Hosp, Bucksburn, Aberdeen, Scotland

来源：

CONTACT DERMATITIS | 2005年 / 53卷 / 03期

关键词：

clinical epidemiology; European standard series; patch test reactions; sensitization frequencies;

D O I：

10.1111/j.0105-1873.2005.00541.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

A 5-year retrospective study of the frequency of sensitization to the 25 allergens of the European standard series (ESS) was conducted in 10 centres in 8 European countries. Included were the results of 26 210 patients. The range in sensitivities differed moderately between the centres. Combining results of different centres and drawing conclusions on incidences can be done only with great care. The information on the ranking of the allergens and their sensitization incidence in the clinics are useful for decisions on the future composition of the standard series. The ESS is still a valid screening tool, and no substances should be deleted.

引用

页码：146 / 149

页数：4

共 13 条

[1] Multicentre patch test studies: are they worth the effort? [J].